BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 11937568)

  • 1. Inhibition of Rho GTPases with protein prenyltransferase inhibitors prevents leukocyte recruitment to the central nervous system and attenuates clinical signs of disease in an animal model of multiple sclerosis.
    Walters CE; Pryce G; Hankey DJR; Sebti SM; Hamilton AD; Baker D; Greenwood J; Adamson P
    J Immunol; 2002 Apr; 168(8):4087-4094. PubMed ID: 11937568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lovastatin inhibits brain endothelial cell Rho-mediated lymphocyte migration and attenuates experimental autoimmune encephalomyelitis.
    Greenwood J; Walters CE; Pryce G; Kanuga N; Beraud E; Baker D; Adamson P
    FASEB J; 2003 May; 17(8):905-7. PubMed ID: 12626426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Geranylgeranylation but not GTP-loading of Rho GTPases determines T cell function.
    Waiczies S; Bendix I; Zipp F
    Sci Signal; 2008 Mar; 1(12):pt3. PubMed ID: 18364514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Actin-Binding Protein Cortactin Promotes Pathogenesis of Experimental Autoimmune Encephalomyelitis by Supporting Leukocyte Infiltration into the Central Nervous System.
    Samus M; Li YT; Sorokin L; Rottner K; Vestweber D
    J Neurosci; 2020 Feb; 40(7):1389-1404. PubMed ID: 31911458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effect of modified peptide inhibitor of alpha4 integrins on experimental allergic encephalomyelitis in Lewis rats.
    van der Laan LJ; van der Goes A; Wauben MH; Ruuls SR; Döpp EA; De Groot CJ; Kuijpers TW; Elices MJ; Dijkstra CD
    J Neurosci Res; 2002 Jan; 67(2):191-9. PubMed ID: 11782963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. t-PA acts as a cytokine to regulate lymphocyte-endothelium adhesion in experimental autoimmune encephalomyelitis.
    Wang J; Zhang X; Mu L; Zhang M; Gao Z; Zhang J; Yao X; Liu C; Wang G; Wang D; Kong Q; Liu Y; Li N; Sun B; Li H
    Clin Immunol; 2014; 152(1-2):90-100. PubMed ID: 24650778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiopoietin-2 blockade ameliorates autoimmune neuroinflammation by inhibiting leukocyte recruitment into the CNS.
    Li Z; Korhonen EA; Merlini A; Strauss J; Wihuri E; Nurmi H; Antila S; Paech J; Deutsch U; Engelhardt B; Chintharlapalli S; Koh GY; Flügel A; Alitalo K
    J Clin Invest; 2020 Apr; 130(4):1977-1990. PubMed ID: 32149735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocyte trafficking through the blood-brain barrier is dependent on endothelial cell heterotrimeric G-protein signaling.
    Adamson P; Wilbourn B; Etienne-Manneville S; Calder V; Beraud E; Milligan G; Couraud PO; Greenwood J
    FASEB J; 2002 Aug; 16(10):1185-94. PubMed ID: 12153986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocyte migration through brain endothelial cell monolayers involves signaling through endothelial ICAM-1 via a rho-dependent pathway.
    Adamson P; Etienne S; Couraud PO; Calder V; Greenwood J
    J Immunol; 1999 Mar; 162(5):2964-73. PubMed ID: 10072547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artesunate Ameliorates Experimental Autoimmune Encephalomyelitis by Inhibiting Leukocyte Migration to the Central Nervous System.
    Thomé R; de Carvalho AC; Alves da Costa T; Ishikawa LL; Fraga-Silva TF; Sartori A; de Oliveira AL; Verinaud L
    CNS Neurosci Ther; 2016 Aug; 22(8):707-14. PubMed ID: 27165523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flavonoids influence monocytic GTPase activity and are protective in experimental allergic encephalitis.
    Hendriks JJ; Alblas J; van der Pol SM; van Tol EA; Dijkstra CD; de Vries HE
    J Exp Med; 2004 Dec; 200(12):1667-72. PubMed ID: 15611292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct roles for matrix metalloproteinase-2 and alpha4 integrin in autoimmune T cell extravasation and residency in brain parenchyma during experimental autoimmune encephalomyelitis.
    Graesser D; Mahooti S; Madri JA
    J Neuroimmunol; 2000 Sep; 109(2):121-31. PubMed ID: 10996214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G protein-coupled receptor kinase 2 in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Vroon A; Kavelaars A; Limmroth V; Lombardi MS; Goebel MU; Van Dam AM; Caron MG; Schedlowski M; Heijnen CJ
    J Immunol; 2005 Apr; 174(7):4400-6. PubMed ID: 15778405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TLR4 contributes to disease-inducing mechanisms resulting in central nervous system autoimmune disease.
    Kerfoot SM; Long EM; Hickey MJ; Andonegui G; Lapointe BM; Zanardo RC; Bonder C; James WG; Robbins SM; Kubes P
    J Immunol; 2004 Dec; 173(11):7070-7. PubMed ID: 15557205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tellurium compound AS101 ameliorates experimental autoimmune encephalomyelitis by VLA-4 inhibition and suppression of monocyte and T cell infiltration into the CNS.
    Lee JH; Halperin-Sheinfeld M; Baatar D; Mughal MR; Tae HJ; Kim JW; Carter A; Lustig A; Snir O; Lavie G; Okun E; Mattson MP; Sredni B; Taub DD
    Neuromolecular Med; 2014 Jun; 16(2):292-307. PubMed ID: 24272426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential targets of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor for multiple sclerosis therapy.
    Nath N; Giri S; Prasad R; Singh AK; Singh I
    J Immunol; 2004 Jan; 172(2):1273-86. PubMed ID: 14707106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytosolic phospholipase A2α blockade abrogates disease during the tissue-damage effector phase of experimental autoimmune encephalomyelitis by its action on APCs.
    Thakker P; Marusic S; Stedman NL; Lee KL; McKew JC; Wood A; Goldman SJ; Leach MW; Collins M; Kuchroo VK; Wolf SF; Clark JD; Hassan-Zahraee M
    J Immunol; 2011 Aug; 187(4):1986-97. PubMed ID: 21746963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of experimental autoimmune encephalomyelitis by a tyrosine kinase inhibitor.
    Constantin G; Laudanna C; Brocke S; Butcher EC
    J Immunol; 1999 Jan; 162(2):1144-9. PubMed ID: 9916745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue Transglutaminase contributes to experimental multiple sclerosis pathogenesis and clinical outcome by promoting macrophage migration.
    van Strien ME; de Vries HE; Chrobok NL; Bol JGJM; Breve JJP; van der Pol SMP; Kooij G; van Buul JD; Karpuj M; Steinman L; Wilhelmus MM; Sestito C; Drukarch B; Van Dam AM
    Brain Behav Immun; 2015 Nov; 50():141-154. PubMed ID: 26133787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of rho family functions by lovastatin promotes myelin repair in ameliorating experimental autoimmune encephalomyelitis.
    Paintlia AS; Paintlia MK; Singh AK; Singh I
    Mol Pharmacol; 2008 May; 73(5):1381-93. PubMed ID: 18239032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.